Torpedo Group Torpedo is where great ideas come to life. We’re a creative agency for the digital world, blending insight, ideas and technology to deliver multi-channel marketing programs that engage ...
Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu (deucravacitinib) in moderate-to-severe scalp psoriasis. Data from the ongoing ...
What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US … ...